BioSpectrum Asia

‘MAINTAININ­G BUSINESS GROWTH GLOBALLY’

-

“Major goals and objectives for EirGenix in 2022 are how to maintain our business growth global-wise and keep our timeline for our products in developmen­t under the pandemic and new threats of COVID-19 virus variants. My projection for 2022 is that the COVID-19 virus variants would still be a threat for us.”

- LEE-CHENG LIU, President and Chief Executive Officer, EirGenix, USA

 ?? ??

Newspapers in English

Newspapers from India